Comparative,Randomized Parallel group,Multicentric Prospective Phase III Clinical trial of FDC of Tolperisone Hcl SR 450mg+ Diclofenac sodium SR100mg tablet OD compared with Tolperisone Hcl 150mg tablet TID for 7 Days in Patients Suffering with Acute Non Specific Low Back Pain.
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Diclofenac/tolperisone (Primary) ; Tolperisone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 15 Feb 2012 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
- 28 Nov 2011 New trial record